COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out
暂无分享,去创建一个
M. Douglas | H. Rashid | M. Eslam | R. Graham | T. Lam | S. Read | J. George | G. Banik | Meryem Jefferies | Xiaojing Zhao | Nausheen Ahmed | G. F. Njiomegnie
[1] P. Dietze,et al. COVID‐19 vaccine acceptability among people in Australia who inject drugs: Implications for vaccine rollout , 2021, Drug and alcohol review.
[2] K. Smolina,et al. Mental Health and Substance Use Associated with Hospitalization among People with COVID-19: A Population-Based Cohort Study , 2021, Viruses.
[3] Sheikh Mohammed Shariful Islam,et al. Increased COVID-19 infection risk, COVID-19 vaccine inaccessibility, and unacceptability: Worrisome trio for patients with substance abuse disorders , 2021, Journal of global health.
[4] D. Taylor,et al. Relation of substance use disorders to mortality, accident and emergency department attendances, and hospital admissions: A 13-year population-based cohort study in Hong Kong. , 2021, Drug and alcohol dependence.
[5] C. Chamberlain,et al. Risk of severe illness from COVID‐19 among Aboriginal and Torres Strait Islander adults: the construct of ‘vulnerable populations’ obscures the root causes of health inequities , 2021, Australian and New Zealand Journal of Public Health.
[6] M. Coleman,et al. Responding to rural adversity: a qualitative study of alcohol and other drug service users’ experiences of service response to COVID-19 in Western Australia’s Southwest , 2021, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.
[7] Anthony F Jorm,et al. Discrimination experienced by Aboriginal and Torres Strait Islander males in Australia: Associations with suicidal thoughts and depressive symptoms , 2021, The Australian and New Zealand journal of psychiatry.
[8] V. Gruber,et al. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs , 2021, Drug and Alcohol Dependence.
[9] L. Galea,et al. The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic , 2021, medRxiv.
[10] K. Mills,et al. Substance use, mental disorders and COVID-19: a volatile mix , 2021, Current opinion in psychiatry.
[11] Christopher M. Jones,et al. Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic. , 2021, JAMA psychiatry.
[12] COVID-19 Australia: Epidemiology Report 33: Fortnightly reporting period ending 17 January 2021 , 2021, Communicable Diseases Intelligence.
[13] anonymous. COVID-19 Australia: Epidemiology Report 33 Fortnightly reporting period ending 17 January 2021. , 2021, Communicable diseases intelligence.
[14] M. Potenza,et al. Trust in a COVID-19 vaccine among people with substance use disorders , 2021, Drug and Alcohol Dependence.
[15] K. Yazdi,et al. Impact of the COVID-19 Pandemic on Patients With Alcohol Use Disorder and Associated Risk Factors for Relapse , 2020, Frontiers in Psychiatry.
[16] J. Levesque,et al. Impact of COVID-19 on healthcare activity in NSW, Australia. , 2020, Public health research & practice.
[17] A. Schimmenti,et al. Facing Loneliness and Anxiety During the COVID-19 Isolation: The Role of Excessive Social Media Use in a Sample of Italian Adults , 2020, Frontiers in Psychiatry.
[18] K. Yazdi,et al. Developments in Drug Addiction During COVID-19—An Austrian Perspective Based on a Clinical Sample , 2020, Frontiers in Psychiatry.
[19] M. Raji,et al. The Impact of Substance Use Disorder on COVID-19 Outcomes. , 2020, Psychiatric services.
[20] E. Seto,et al. Stress, Anxiety, and Change in Alcohol Use During the COVID-19 Pandemic: Findings Among Adult Twin Pairs , 2020, Frontiers in Psychiatry.
[21] A. Kam,et al. Fewer presentations to metropolitan emergency departments during the COVID‐19 pandemic , 2020, The Medical journal of Australia.
[22] N. Volkow,et al. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States , 2020, Molecular Psychiatry.
[23] G. Martinotti,et al. Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy , 2020, Frontiers in Psychiatry.
[24] G. D’Onofrio,et al. Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID-19 Pandemic in the US , 2020, JAMA internal medicine.
[25] B. Marshall,et al. Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs , 2020, International Journal of Drug Policy.
[26] Jessica L. Willis. Closing the gap - 2020 marks a new era , 2020 .
[27] Subhankar Chatterjee,et al. Psychosocial impact of COVID-19 , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[28] J. Mackolil,et al. Addressing psychosocial problems associated with the COVID-19 lockdown , 2020, Asian Journal of Psychiatry.
[29] P. Haber,et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic , 2020, Harm Reduction Journal.
[30] T. Green,et al. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken , 2020, Nature Medicine.
[31] T. Clausen,et al. COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper , 2020, Basic and clinical neuroscience.
[32] C. Hassan,et al. Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy , 2020, Gastroenterology.
[33] K. Humphreys,et al. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. , 2020, Addiction.
[34] G. Alexander,et al. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19 , 2020, Annals of Internal Medicine.
[35] Liz J Walker. 2019-nCoV acute respiratory disease, Australia - Epidemiology Report 1 (Reporting week 26 January – 1 February 2020) , 2020 .
[36] T. Rummans,et al. Infectious diseases occurring in the context of substance use disorders: A concise review , 2020, Journal of the Neurological Sciences.
[37] J. Weiner,et al. Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study. , 2020, Annals of emergency medicine.
[38] Aaron W. Cashmore,et al. Can a continuous quality improvement program create culturally safe emergency departments for Aboriginal people in Australia? A multiple baseline study , 2019, BMC Health Services Research.
[39] C. Holland. Close the gap 2018 - a ten year review: the Closing the Gap strategy and recommendations for reset , 2018 .
[40] M. Lincoln,et al. Improving the efficacy of healthcare services for Aboriginal Australians. , 2018, Australian health review : a publication of the Australian Hospital Association.
[41] D. Satre,et al. Alcohol, Marijuana, and Opioid use Disorders: 5-Year Patterns and Characteristics of Emergency Department Encounters , 2018, Substance abuse.
[42] A. Boyle,et al. Emergency department-based interventions for women suffering domestic abuse: a critical literature review , 2017, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[43] S. Irving,et al. Preventing intimate partner violence across the lifespan : a technical package of programs, policies, and practices , 2017 .
[44] A. Crosby,et al. Preventing suicide : a technical package of policies, programs, and practice , 2017 .
[45] A. Lyons,et al. Opioid Substitution Treatment Planning in a Disaster Context: Perspectives from Emergency Management and Health Professionals in Aotearoa/New Zealand , 2016, International journal of environmental research and public health.
[46] J. Poorolajal,et al. Substance use disorder and risk of suicidal ideation, suicide attempt and suicide death: a meta-analysis. , 2016, Journal of public health.
[47] C. Runyan,et al. Lethal Means Counseling for Parents of Youth Seeking Emergency Care for Suicidality , 2016, The western journal of emergency medicine.
[48] F. Vaca,et al. Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies , 2015, The Yale journal of biology and medicine.
[49] K. Carrington,et al. Domestic violence (DV) service provision and the architecture of rural life: An Australian case study , 2015 .
[50] N. Drew,et al. Overview of Aboriginal and Torres Strait Islander health status, 2015 , 2015 .
[51] Steven A R Webb,et al. Accuracy of International classification of diseases, 10th revision codes for identifying severe sepsis in patients admitted from the emergency department. , 2012, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[52] N. Thomson. Australian Indigenous HealthInfoNet , 2005 .
[53] E. Englev,et al. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives]. , 2003, Ugeskrift for laeger.